questionText: To ask the Secretary of State for Health and Social Care, whether she has made an assessment of the potential impact of off-label prescriptions of Victoza, Luraglutide, for the purpose of weight loss from private healthcare providers on the level of suppl
answerText: While the position has improved, there continues to be a global supply issue with glucagon-like peptide-1 receptor agonists (GLP-1 RA), including Victoza (liraglutide). We have issued updated guidance to healthcare professionals in the form of a National ...
heading: Liraglutide